Uterine serous carcinoma
Authors:
- Diana MiaoDMDiana Miao
- Lora Hedrick EllensonLELora Hedrick Ellenson
- Amanda N. FaderAFAmanda N. Fader
- 30 July 2022
- book chapter
- Published by Elsevier
- p. 197-212
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- The Clinical Relevance of Rising CA-125 Levels Within the Normal Range in Patients With Uterine Papillary Serous CancerReproductive Sciences, 2013
- Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinomaProceedings of the National Academy of Sciences, 2013
- Nodal Metastasis Risk in Endometrioid Endometrial CancerObstetrics & Gynecology, 2012
- Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2Journal of Clinical Oncology, 2009
- Molecular Identification of “Latent Precancers” for Endometrial Serous Carcinoma in Benign-Appearing EndometriumThe American Journal of Pathology, 2009
- Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumorsAmerican Journal of Obstetrics and Gynecology, 2007
- Minimal uterine serous carcinoma: a clinicopathological study of 40 casesLaboratory Investigation, 2005
- Association between uterine serous carcinoma and breast cancerGynecologic Oncology, 2004
- Is Uterine Serous Papillary Carcinoma a BRCA1-Related Disease? Case Report and Review of the LiteratureGynecologic Oncology, 1999